0001144204-15-061931.txt : 20151030
0001144204-15-061931.hdr.sgml : 20151030
20151030163031
ACCESSION NUMBER: 0001144204-15-061931
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151028
FILED AS OF DATE: 20151030
DATE AS OF CHANGE: 20151030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: China Biologic Products, Inc.
CENTRAL INDEX KEY: 0001369868
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 752308816
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
BUSINESS PHONE: 86-10-6598-3111
MAIL ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
FORMER COMPANY:
FORMER CONFORMED NAME: GRC Holdings, Inc.
DATE OF NAME CHANGE: 20060721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gao David
CENTRAL INDEX KEY: 0001331795
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34566
FILM NUMBER: 151187873
MAIL ADDRESS:
STREET 1: C/ BEIJING MED-PHARM CORPORATION
STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
v423308_4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-10-28
0
0001369868
China Biologic Products, Inc.
CBPO
0001331795
Gao David
18TH FLOOR, JIALONG INTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING
F4
100125
CHINA
1
1
0
0
Chief Executive Officer
Common Stock
2015-10-28
4
S
0
61660
110.23
D
495340
D
Common Stock
2015-10-29
4
S
0
9458
110.08
D
485882
D
Represents 71,118 shares of common stock sold through a 10b5-1 trading plan previously disclosed on the Reporting Person's Form 4 filed with the Securities and Exchange Commission (the "Commission") on October 21, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.78, inclusive.*
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.96, inclusive.*
* The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3.
/s/ David (Xiaoying) Gao
2015-10-30